Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International U. joined GRACE to discuss biomarkers for predicting activity of immune checkpoint inhibitors.
Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International U. joined GRACE to discuss potential side effects of immune checkpoint inhibitors and basic management approaches.
Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International U. joined GRACE to discuss integrating immune checkpoint inhibitors into first-line therapy for advanced NSCLC.
Dr. Luis Raez, MD FACP FCCP, Chief of Hematology/Oncology and Med. Director at Memorial Cancer Institute, and Clinical Associate Professor of Medicine at FL International University joined GRACE to discuss immune checkpoint inhibitors and how they can treat cancer.
Dr. Luis Raez, MD FACP FCCP, Chief of Hematology/Oncology and Medical Director at Memorial Cancer Institute, and Clinical Associate Professor of Medicine at Florida International University joined GRACE to discuss molecular marker testing for advanced NSCLC.
Is Palliative Care Right for You? Submitted by JanineT Forum Moderator on Mon, 07/22/2019 - 12:36 From the Grace Archives | Originally published March...
El sexo es esa palabra que puede significar y sentirse de forma tan diferente dependiendo del contexto de nuestras vidas. Como jóvenes adolescentes...
CLICK HERE TO WATCH THE EVENT ONDEMAND The 2022 English Targeted Therapies Patient Forums is Now Over. For further detail, please click here.
GRACE is pleased to announce the acceptance of four rising stars into the 4th year of the GRACE Patient Education Ambassadors Program for the 2022-23...
We are excited to launch our second year of this program - Patient Perspectives - Clinical Trials Experiences Through Storytelling GRACE’s mission is...
At 58, my dad as a non-smoker was diagnosed with stage 3c, assumed 4, adenocarcinoma of the lung. It's spread to his local lymph nodes and also into...
all the weed in the world is not working right now. Diagnosed 8/16/21 large mass in sigmon colon. Stage 111b. Surgery in September. Two nodes infected...
Background: Previously had testicular cancer (the really "good" and "curable" kind) that was caught early, I'm in my late 30s -- this was ~18 months...
Hi, I’m 23 years old and starting last year around march or so I started to get this pain in my shoulder blade where it felt like it needed to be...
Hello, my mother was diagnosed with stage 4 lung cancer with metastasis to different areas. She is a 50 year old lady (non smoker). Our oncologist at...
Dr. Luis Raez, MD FACP FCCP, Chief of Hematology/Oncology and Medical Director at Memorial Cancer Institute, and Clinical Associate Professor of Medicine at Florida International University joined GRACE to discuss molecular marker testing for advanced NSCLC.
Dr. Luis Raez, MD FACP FCCP, Chief of Hematology/Oncology and Medical Director at Memorial Cancer Institute, and Clinical Associate Professor of Medicine at Florida International University joined GRACE to discuss treating early stage NSCLC.
Let me start by saying that I'm a fan of the immune checkpoint inhibitor Keytruda (pembrolizumab) and consider it the new standard of care as a single agent (monotherapy) first line treatment for the subset of about 28-30% of patients with advanced NSCLC, either squamous or non-squamous, whose cancers have high level expression
For our 17th video in the GRACE Spanish Lung Cancer Library, Brian Hunis, MD joined GRACE to discuss first line therapy for NSCLC patients that have anaplastic lymphoma kinase (ALK) positive.
On November 4th, 2016, in collaboration with UNC Lineberger and Lung Cancer Initiative of NC, GRACE presented 'Not Your Father's Squamous Lung Cancer'. Our last presentation discusses supportive care for patients, with Amber Procter, PharmD, and Jason Akulian, MD.
On November 4th, 2016, in collaboration with UNC Lineberger and Lung Cancer Initiative of NC, GRACE presented 'Not Your Father's Squamous Lung Cancer'. Our third presentation discusses future directions in treatment, with Chad Pecot, MD.
For our 16th video in the GRACE Spanish Lung Cancer Library, Brian Hunis, MD joined GRACE to discuss ALK rearrangements, what they are who has them.
On November 4th, 2016, in collaboration with UNC Lineberger and Lung Cancer Initiative of NC, GRACE presented 'Not Your Father's Squamous Lung Cancer'. In this 2nd video of the series, Jared Weiss, MD joins us to discuss currently available treatment options.
For our 15th video in the GRACE Spanish Lung Cancer Library, Brian Hunis, MD joined GRACE to discuss treating later stage small cell lung cancer.
On November 4th, 2016, in collaboration with UNC Lineberger and Lung Cancer Initiative of NC, GRACE presented 'Not Your Father's Squamous Lung Cancer'. In this first video of the series, Dr. Chad Pecot, MD joins us to discuss 'What is squamous lung cancer?'
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.